Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT00109044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to evaluate the efficacy and safety of a fixed-dose escitalopram combination relative to its component monotherapies and to placebo in patients with major depressive disorder.
Study identification
- NCT ID
- NCT00109044
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 540 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2005
- Primary completion
- Apr 30, 2006
- Completion
- Apr 30, 2006
- Last update posted
- Mar 4, 2012
2005 – 2006
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Health, Ltd | Phoenix | Arizona | 85016 | — |
| Alpine Clinical Research | Boulder | Colorado | 80304 | — |
| Radiant Research, Inc. | Denver | Colorado | 80212 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32806 | — |
| Cunningham Clinical Research, LLC | Edwardsville | Illinois | 62025 | — |
| Midwest Center for Neurobiological Medicine | Oakbrook Terrace | Illinois | 60181 | — |
| Capital Clinical Research Associates | Rockville | Maryland | 20852 | — |
| Summit Research Network (Michigan), Inc. | Okemos | Michigan | 48864 | — |
| CNS Research Institute | Clementon | New Jersey | 08021 | — |
| Center for Emotional Fitness | Moorestown | New Jersey | 08057 | — |
| Eastside Comprehensive Medical Center | New York | New York | 10021 | — |
| Piedmont Medical Research Associates, Inc. | Winston-Salem | North Carolina | 27103 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| Claghorn-Lesem Research Clinic | Bellaire | Texas | 77401 | — |
| Croft Group Research Center | San Antonio | Texas | 78229 | — |
| Dominion Clinical Research | Midlothian | Virginia | 23112-3989 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98004 | — |
| Summit Research Network (Seattle), LLC | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00109044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2012 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00109044 live on ClinicalTrials.gov.